By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health has awarded $110 million to fund the second phase of its Knockout Mouse Project (KOMP), an initiative to create a disease research resource that in its first phase created knockout mouse embryonic stem cell lines for the roughly 21,000 coding genes in the mouse.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.